Scholar Rock Ownership | Who Owns Scholar Rock?
Scholar Rock Ownership Summary
Scholar Rock is owned by 11.19% institutional investors, 1.14% insiders, and 87.67% retail investors. Fmr is the largest institutional shareholder, holding 14.05% of SRRK shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.05% of its assets in Scholar Rock shares.
SRRK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Scholar Rock | 11.19% | 1.14% | 87.67% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 13.64M | 14.05% | $589.32M |
| Artal group | 11.26M | 11.74% | $93.79M |
| Price t rowe associates inc /md/ | 9.28M | 9.57% | $401.23M |
| Siren | 9.25M | 9.53% | $399.79M |
| Blackrock funding, inc. /de | 7.17M | 7.39% | $309.99M |
| Blackrock | 5.66M | 5.91% | $47.18M |
| Samsara biocapital | 5.61M | 5.78% | $242.59M |
| Vanguard group | 4.74M | 4.89% | $205.01M |
| Redmile group | 4.55M | 4.69% | $196.65M |
| Polar capital | 2.94M | 3.07% | $24.50M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Samsara biocapital | 5.61M | 33.30% | $242.59M |
| Siren | 9.25M | 17.66% | $399.79M |
| Redmile group | 4.55M | 13.70% | $196.65M |
| Fairmount funds management | 1.96M | 8.43% | $84.84M |
| Octagon capital advisors lp | 488.00K | 3.47% | $21.09M |
| Commodore capital lp | 950.00K | 3.01% | $41.06M |
| Bioimpact capital | 416.14K | 2.55% | $17.99M |
| Exome asset management | 77.44K | 2.51% | $3.35M |
| Artal group | 11.26M | 2.39% | $93.79M |
| Ikarian capital | 357.19K | 2.10% | $15.44M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 13.64M | 0.04% | 3.44M |
| Marshall wace, llp | 2.95M | 0.15% | 2.73M |
| Norges bank | 1.99M | 0.01% | 1.99M |
| Fairmount funds management | 1.96M | 8.43% | 1.96M |
| Adage capital partners gp | 1.59M | 0.12% | 1.59M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Siren | 9.25M | 17.66% | -2.01M |
| State street | 2.81M | 0.00% | -1.36M |
| Samsara biocapital | 5.61M | 33.30% | -1.18M |
| Redmile group | 4.55M | 13.70% | -688.96K |
| Abrdn | 142.19K | 0.01% | -606.30K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.99M | 0.01% | 1.99M | $86.04M |
| Fairmount funds management | 1.96M | 8.43% | 1.96M | $84.84M |
| Commodore capital lp | 950.00K | 3.01% | 950.00K | $41.06M |
| Loomis sayles & co l p | 776.66K | 0.04% | 776.66K | $33.57M |
| Capital world investors | 721.96K | 0.00% | 721.96K | $31.20M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -11.00 |
| Innealta capital | -48.00 |
| Capital performance advisors llp | -99.00 |
| Cape investment advisory | -100.00 |
| National bank of canada /fi/ | -104.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 71 | -58.72% | 10,857,075 | -87.43% | 11 | 0.14% | 47 | -44.05% | 15 | -71.70% |
| Sep 30, 2024 | 172 | 3.61% | 86,355,530 | 1.71% | 88 | 1.13% | 84 | -16.83% | 53 | 26.19% |
| Jun 30, 2024 | 166 | 1.22% | 84,906,035 | 0.71% | 88 | 1.15% | 101 | 12.22% | 42 | -8.70% |
| Mar 31, 2024 | 164 | 22.39% | 84,308,074 | 4.71% | 87 | 0.94% | 90 | -21.05% | 46 | 318.18% |
| Dec 31, 2023 | 134 | 47.25% | 80,517,894 | 49.48% | 96 | 2.16% | 114 | 70.15% | 11 | -26.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 4.78M | 5.05% | 82.52K |
| Fidelity Growth Compy Commingled Pl O | 3.59M | 4.49% | 36.80K |
| US Small-Cap Growth II Equity Comp | 4.03M | 4.31% | 111.66K |
| T. Rowe Price New Horizons | 3.96M | 4.19% | - |
| Fidelity Growth Company Fund | 3.40M | 3.59% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.67M | 2.82% | 1.81K |
| BB Biotech AG Ord | 2.49M | 2.66% | 353.98K |
| Polar Capital Biotech S Inc | 2.38M | 2.51% | - |
| Vanguard US Total Market Shares ETF | 2.29M | 2.42% | - |
| T. Rowe Price Health Sciences | 2.15M | 2.27% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 24, 2025 | Sacco Tracey | Chief Commercial Officer | Sell | $164.46K |
| Mar 24, 2025 | Sacco Tracey | Chief Commercial Officer | Sell | $50.56K |
| Mar 24, 2025 | Moore Erin | Interim PFO and PAO | Sell | $449.24K |
| Mar 17, 2025 | Peng Katie | - | Sell | $34.63K |
| Mar 10, 2025 | Myles Edward H | COO & CFO | Sell | $1.03M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 21 |
| 2024 Q4 | - | 25 |
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 4 |
| 2024 Q1 | - | 9 |
SRRK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools